» Articles » PMID: 34802352

Mediators and Moderators of ART Adherence Effects of Supporting Treatment Adherence Readiness Through Training (START): Evidence That START Helps Vulnerable Clients Achieve Better Adherence

Overview
Journal AIDS Care
Publisher Informa Healthcare
Date 2021 Nov 22
PMID 34802352
Authors
Affiliations
Soon will be listed here.
Abstract

Supporting Treatment Adherence Readiness through Training (START) is an HIV antiretroviral adherence intervention, based on the Information Motivation and Behavioral skills (IMB) model, that significantly improved adherence in our randomized controlled trial. To understand how and for whom START had its effects on adherence, we examined mediators and moderators. Ninety-nine HIV-patients (53 control, 46 intervention) who enrolled in the trial and provided month 6 electronic monitored adherence data. The intervention was associated with increased adherence-related knowledge and lower impulsive/careless problem solving, but had no effects on other IMB-related constructs. Neither of these variables mediated the adherence effects of the intervention (based on linear regression models with bootstraping for unbiased standard errors). Four variables interacted with the intervention to moderate its effects: the intervention group had consistent high adherence across the range of depression and time since HIV diagnosis, compared to lower adherence with higher values in the usual care control; those with unstable housing or frequent drug use had higher adherence if in the intervention group compared to the control group. These findings suggest that START provides support that enables its recipients to cope with and overcome challenges (e.g., depression, unstable housing, drug use) that would typically impede adherence. ClinicalTrials.gov identifier: NCT02329782.

References
1.
Mbuagbaw L, Sivaramalingam B, Navarro T, Hobson N, Keepanasseril A, Wilczynski N . Interventions for Enhancing Adherence to Antiretroviral Therapy (ART): A Systematic Review of High Quality Studies. AIDS Patient Care STDS. 2015; 29(5):248-66. PMC: 4410452. DOI: 10.1089/apc.2014.0308. View

2.
Robbins R, Spector A, Mellins C, Remien R . Optimizing ART adherence: update for HIV treatment and prevention. Curr HIV/AIDS Rep. 2014; 11(4):423-33. PMC: 4268351. DOI: 10.1007/s11904-014-0229-5. View

3.
Harris R, Xue X, Selwyn P . Housing Stability and Medication Adherence among HIV-Positive Individuals in Antiretroviral Therapy: A Meta-Analysis of Observational Studies in the United States. J Acquir Immune Defic Syndr. 2016; 74(3):309-317. PMC: 5305290. DOI: 10.1097/QAI.0000000000001213. View

4.
Johnson M, Elliott T, Neilands T, Morin S, Chesney M . A Social Problem-Solving Model of Adherence to HIV Medications. Health Psychol. 2006; 25(3):355-363. PMC: 2432423. DOI: 10.1037/0278-6133.25.3.355. View

5.
Simoni J, Amico K, Smith L, Nelson K . Antiretroviral adherence interventions: translating research findings to the real world clinic. Curr HIV/AIDS Rep. 2010; 7(1):44-51. PMC: 3607373. DOI: 10.1007/s11904-009-0037-5. View